Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To find drug formulation information in patents
— Pharmaceutical developtment, Brazil
To track filing and history of various APIs
— API research and development, USA
For information about active patents for the development of new OTC products
— Pharmaceutical consultant, France
To identify patent expiration dates
— Medicine sourcing, Malaysia
For drug patent information
— Pharmaceutical business developer, USA
Generated: May 26, 2017
What is the patent landscape for Temovate E, and what generic Temovate E alternatives are available?
Temovate E is a drug marketed by Fougera Pharms and is included in one NDA.| Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: see list | 40 |
| Patent Applications: see list | 5,721 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | TEMOVATE E at DailyMed |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fougera Pharms | TEMOVATE E | clobetasol propionate | CREAM;TOPICAL | 020340-001 | Jun 17, 1994 | DISCN | Yes | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents
Available with subscription
Paragraph IV Activity
Available with subscription
Patent Maintenance
Available with subscription
Non-Orange Book Patents
Available with subscription
International Patents
Available with subscription
Supplementary Protection Certificates
Available with subscription
For paragraph IV challenge research
— Pharmaceutical company, USA
To explore which pharmaceutical products are still under patent protection
— Managing partner for pharmaceutical company, Lebanon
To review patents of pharmaceutical products
— Pharmaceutical regulatory affairs, India
To get patent/product expiration details and freedom-to-operate opportunities
— API development, India
To gain information on when to expect generics on the market in order to inform patients of when they can expect more affordable drugs
— Retail pharmacist, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
